ATRIANCE sol perf 250 mg/50ml flac 50 ml
7680578990021
CH-57899
L01BB07
07.16.1.
Reimbursement limitations:
ATRIANCE
Traitement de patients souffrant de leucémie aiguë lymphoblastique à lymphocytes T et de lymphome lymphoblastique …
1 / 3
google
Details
- Product number
- 5789902
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- nelarabinum 250 mg, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 89.075 mg.
Articles (1)
Atriance, Infusionslösung
Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
89.075 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 336.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2021
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57899
- Drug name
- Atriance, Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L01BB07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/08/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ATRIANCE sol perf 250 mg/50ml flac 50 ml
- Description (DE)
- ATRIANCE Inf Lös 250 mg/50ml Durchstf 50 ml
- Market launch
- 08/08/2007
- Narcotic (BTM)
- No